Literature DB >> 29945975

Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?

Andrea Cortegiani1, Antonino Giarratano2.   

Abstract

Entities:  

Keywords:  Candida spp.; antifungal drug; empirical treatment; prophylaxis; untargeted treatment

Mesh：

Substances：

Year:  2018        PMID： 29945975      PMCID： PMC6021644          DOI： 10.1128/AAC.00810-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery.

Authors:  Pavel S Roshanov; Brittany B Dennis; Nicholas Pasic; Amit X Garg; Michael Walsh
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

2.  Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Antonino Giarratano
Journal:  JAMA       Date:  2017-01-17       Impact factor: 56.272

Review 3.  Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Alessandra Maggiore; Massimo Attanasio; Alessandro R Naro; Santi Maurizio Raineri; Antonino Giarratano
Journal:  Cochrane Database Syst Rev       Date:  2016-01-16

4.  Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.

Authors:  Yan Wang; Jiao Xie; Yuanming Xing; Lu Chen; Ying Li; Ti Meng; Weihua Dong; Xue Wang; Yalin Dong
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

5.  Trial Sequential Analysis in systematic reviews with meta-analysis.

Authors:  Jørn Wetterslev; Janus Christian Jakobsen; Christian Gluud
Journal:  BMC Med Res Methodol       Date:  2017-03-06       Impact factor: 4.615
  5 in total
  1 in total

1.  Reply to Cortegiani and Giarratano, "Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?"

Authors:  Yalin Dong; Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.